| Pharmaceutical active ingredients: |
| Carbocisteine |
| Available forms, composition and doses of Tussantiol: |
| Syrup; Oral; Carbocisteine 250 mg / 5 ml |
| Tussantiol medical category: |
| Human:Cough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CB03 - Carbocisteine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Medisa |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tussanil Compositum | Drosera; Eucalyptus Oil; Liquorice; Noscapine; Peppermint Oil | Vifor Pharma |
| Tussanil DH Syrup | Chlorpheniramine Maleate; Hydrocodone Tartrate; Phenylephrine Hydrochloride | Edwards Pharmaceuticals |
| Tussanil DH Tablets | Guaifenesin; Hydrocodone Tartrate; Phenylpropanolamine Hydrochloride | Edwards Pharmaceuticals |
| Tussanil N | Noscapine Hydrochloride | Vifor Pharma |
| Tussanil Plain | Chlorpheniramine Maleate; Phenylephrine Hydrochloride | Edwards Pharmaceuticals |
| Tussanyl | Grindelia; Sulfogaiacol | Giovanardi Farmaceutici del Dr. Benito Giovanardi e Figli |
| Tussapap | Acetaminophen | Unidentified Pharmaceutical Company |
| Tussaphed | Pseudoephedrine | Unidentified Pharmaceutical Company |
| Tussar DM | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride | Sanofi-Aventis |
| Tussar SF | Codeine Phosphate; Guaifenesin; Pseudoephedrine Hydrochloride | Sanofi-Aventis |